PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 85 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,000 | +100.0% | 6,637 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 6,637 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 6,637 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -96.7% | 6,637 | -95.6% | 0.00% | – |
| Q1 2016 | $60,000 | -63.0% | 150,953 | +8.7% | 0.00% | – |
| Q4 2015 | $162,000 | +19.1% | 138,899 | +4.6% | 0.00% | – |
| Q3 2015 | $136,000 | -19.5% | 132,770 | +2.7% | 0.00% | – |
| Q2 2015 | $169,000 | -3.4% | 129,288 | -0.3% | 0.00% | – |
| Q1 2015 | $175,000 | +1.2% | 129,707 | +4.1% | 0.00% | – |
| Q4 2014 | $173,000 | +8.1% | 124,590 | +5.8% | 0.00% | – |
| Q3 2014 | $160,000 | -25.6% | 117,737 | +3.0% | 0.00% | – |
| Q2 2014 | $215,000 | -10.0% | 114,311 | -9.3% | 0.00% | – |
| Q1 2014 | $239,000 | +44.0% | 125,979 | +5.7% | 0.00% | – |
| Q4 2013 | $166,000 | +7.1% | 119,146 | +8.6% | 0.00% | – |
| Q3 2013 | $155,000 | +10.7% | 109,677 | +0.7% | 0.00% | – |
| Q2 2013 | $140,000 | – | 108,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |